Katherine J. Lepik
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Adverse drug reactions attributed to generic substitution of antiretroviral medications among HIV treatment and pre-exposure prophylaxis clients in British Columbia, Canada.
Journal: Antiviral therapy
Published: February 20, 2024
Process description of developing HIV prevention monitoring indicators for a province-wide pre-exposure prophylaxis (PrEP) program in British Columbia, Canada.
Journal: PloS one
Published: October 27, 2022
Evolving patterns of antiretroviral drug interactions in people with HIV in British Columbia, Canada.
Journal: AIDS (London, England)
Published: March 14, 2022
Impact of combinations of clinically observed HIV integrase mutations on phenotypic resistance to integrase strand transfer inhibitors (INSTIs): a molecular study.
Journal: The Journal of antimicrobial chemotherapy
Published: September 11, 2021
Evaluation of a Public Health Referral System to Re-Engage Individuals Living With HIV Who Have Interrupted Antiretroviral Therapy in British Columbia, Canada.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: June 25, 2021
Untimed Efavirenz Drug Levels After Switching From Brand to Generic Formulations: A Short Communication.
Journal: Therapeutic drug monitoring
Published: August 11, 2020
Prevalence of Human Immunodeficiency Virus-1 Integrase Strand Transfer Inhibitor Resistance in British Columbia, Canada Between 2009 and 2016: A Longitudinal Analysis.
Journal: Open forum infectious diseases
Published: November 15, 2018
Adverse drug reactions to integrase strand transfer inhibitors.
Journal: AIDS (London, England)
Published: February 10, 2018
Emergent drug resistance with integrase strand transfer inhibitor-based regimens.
Journal: AIDS (London, England)
Published: April 05, 2017
Vets, denialists and rememberers: social typologies of patient adherence and non-adherence to HAART from the perspective of HIV care providers.
Journal: AIDS care
Published: January 31, 2015
Post-marketing experience with nevirapine extended release (XR) tablets: effectiveness and tolerability in a population-based cohort in British Columbia, Canada.
Journal: Antiviral therapy
Published: October 15, 2014
Last Updated: 09/26/2026